pharma · Multiple Myeloma · Ovarian Cancer
pharma&
pharmaand GmbH
pharmaand is a pharma organization headquartered in Wien, AT. Primary therapeutic focus areas include Multiple Myeloma, Ovarian Cancer. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s
Company details
- Status
- Public
- HQ
- Vienna, AT
- Founded
- 2017
- Employees
- 210
- Programs
- 3
- Drugs
- 16
- Patents
- 0
Panobinostat Capsules
Phase 2 · small molecule · Multiple Myeloma
Panobinostat Capsules for Multiple Myeloma is a Phase 2 program (small_molecule) at pharmaand GmbH with 1 ClinicalTrials.gov record(s).
Internal code CLBH589D2222
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- pharmaand GmbH
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Multiple Myeloma
- Status
- completed
- Trials
- 1